Brazil’s Health Ministry has signed an agreement with Indian pharmaceutical company Bharat Biotech to procure 20 million doses of Covaxin vaccine, reports Money Control.
The development comes on the day as the fatalities due to Covid-19 deaths reached 2, 50,000 in the South American country.
President Jair Bolsonaro’s administration announced that the initial eight million shots of Covaxin, which will be made by Brazilian company Precisa Medicamentos, will arrive in the country in early March.
Subsequently, the next batch of eight million doses will be delivered in April and the final four million shots will reach the country in May.
It should be noted that Bharat Biotech had signed an agreement with Precisa Medicamentos in January for the supplies of COVAXIN to Brazil.
Meanwhile, Brazil has vaccinated only four per cent of its 210 million population so far.
Last week, some Brazilian cities had to halt their immunization campaigns due to shortage of vaccine shots. Until now, neither Bharat Biotech nor Precisa Medicamentos have confirmed these orders nor have they officially stated any delivery dates.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.